0000000000347933

AUTHOR

Massimo Licata

showing 1 related works from this author

RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE St…

2022

Noninvasive criteria to predict the progression of low-risk esophageal varices (EV) in patients with compensated hepatitis C virus (HCV) cirrhosis after sustained virological response (SVR) by direct-acting antivirals (DAAs) are lacking. Our aim was to assess the diagnostic performance of Rete Sicilia Selezione Terapia-HCV (RESIST-HCV) criteria for EV progression compared with elastography-based criteria (Baveno VI, Expanded Baveno VI, and Baveno VII-HCV criteria).All consecutive patients observed at 3 referral centers with compensated HCV cirrhosis with or without F1 EV who achieved sustained virological response by DAAs were classified at last esophagogastroduodenoscopy (EGDS) as RESIST-H…

Antiviral AgentMaleLiver CirrhosisHepatologyPlatelet CountLiver CirrhosiGastroenterologyHepacivirusHepatitis C ChronicEsophageal and Gastric VaricesAntiviral AgentsElasticity Imaging Techniques.Esophageal and Gastric VariceHumansElasticity Imaging TechniquesFemaleSerum AlbuminHumanAgedThe American journal of gastroenterology
researchProduct